Generic name: HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN 1000000[CCID_50] in 1mL;
Dosage form: oral applicator
Medically reviewed by Drugs.com. Last updated on Nov 12, 2019.
Reconstitution Instructions for Oral Administration
For oral use only. Not for injection.
Reconstitute only with accompanying diluent. Do not mix ROTARIX with other vaccines or solutions.
Recommended Dose and Schedule
The vaccination series consists of two 1-mL doses administered orally. The first dose should be administered to infants beginning at 6 weeks of age. There should be an interval of at least 4 weeks between the first and second dose. The 2-dose series should be completed by 24 weeks of age.
Safety and effectiveness have not been evaluated if ROTARIX were administered for the first dose and another rotavirus vaccine were administered for the second dose or vice versa.
In the event that the infant spits out or regurgitates most of the vaccine dose, a single replacement dose may be considered at the same vaccination visit.
Breastfeeding was permitted in clinical studies. There was no evidence to suggest that breastfeeding reduced the protection against rotavirus gastroenteritis afforded by ROTARIX. There are no restrictions on the infant’s liquid consumption, including breast milk, either before or after vaccination with ROTARIX.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Rotarix (rotavirus vaccine)
- Side Effects
- During Pregnancy
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: viral vaccines
- FDA Alerts (2)
- FDA Approval History
Other brands: RotaTeq